Nanostructured lipid carriers as a delivery system of biochanin A

Drug Delivery

Volumn 20, Issue 8, 2013, Pages 331-337

  Wang, Qiang ^a   Cheng, Hailin ^a,b   Zhou, Kai ^a   Wang, Lei ^a   Dong, Shixin ^c   Wang, Dianlei ^a   Chen, Weidong ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^b Anhui Provincal Hospital   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biochanin A; Delivery system; Emulsion evaporation and low temperature solidification; Nanostructured lipid carriers; Pharmacokinetics

Indexed keywords

BIOCHANIN A; GLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; EMULSION; EVAPORATION; IN VITRO STUDY; LOW TEMPERATURE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; X RAY DIFFRACTION; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; GENISTEIN; LIPIDS; NANOSTRUCTURES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; X-RAY DIFFRACTION;

EID: 84885653287     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.838716     Document Type: Article

References (31)

1. Atkinson C, Compston JE, Day NE, et al. (2004). The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79: 326-33. (Pubitemid 41095988)
2. Bargoni A, Cavalli R, Caputo O, et al. (1998). Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 15: 745-50. (Pubitemid 28275652)
3. Bhandari R, Kaur IP. (2013). Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid solid lipid nanoparticles. Int J Pharm 441: 202-12.
4. Cassady JM, Zennie TM, Chae YH, et al. (1988). Use of a mammalian cell culture benzo(a) pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res 48: 6257-61.
5. Chedeaui P, San Miquel G, Hidalgo L, et al. (2008). Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 24: 620-4.
6. Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T, et al. (2011). Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm Sci Tech 13: 150-8.
7. Chirio D, Gallarate M, Peira E, et al. (2011). Formulation of curcuminloaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Mroencapsul 28: 637-48.
8. DaiW, Zhang D, Duan C, et al. (2010). Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. J Microencapsul 27: 234-41.
9. Das S, Chaudhury A. (2011). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharmasci Tech 12: 62-76.
10. Florence AT. (1997). The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharm Res 14: 259-66. (Pubitemid 27160935)
11. Haede H, Das M, Jain S. (2011). Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 8: 1407-24.
12. Han HK, Lee BJ, Lee HK. (2011). Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion in vitro and in vivo evaluation. Int J Pharm 415: 89-94.
13. Harini R, Ezhumalai M, Pugalendi KV. (2012). Antihyperglycemic effect of biochanin A, a soy isoflavone, one steptozotocindiabetic rats. Eur J Pharmacol 676: 89-94.
14. Huang X, Chen YJ, Peng DY, et al. (2013). Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B Biointerfaces 102: 391-7.
15. Howes JB, Sullivan D, Lai N, et al. (2000). The effects of dietary supplement with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152: 143-7.
16. Jia LJ Zhang DR, Li ZY, et al. (2010). Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 17: 11-8.
17. Kole L, Giri B, Manna SK, et al. (2011). Biochanin A, an isoflavon, showed antiproliferative and anti- inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NF-B nuclear translocation. Eur J Pharmacol 25: 8-15.
18. Lee MK, Lim SJ, Kim CK. (2007). Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28: 2137-46.
19. Manjunath K, Reddy JS, Venkateswarlu V. (2005). Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 27: 127-44.
20. Mehnert W, Mader K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47: 165-96. (Pubitemid 32324113)
21. Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54: 131-55.
22. Müller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50: 161-77. (Pubitemid 30326695)
23. Müller RH, Sheqokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial application. Curr Drug Discov Technol 8: 207-27.
24. Moon YJ, Morris ME. (2007). Pharmacokinetics and bioavailability of the bioflavonoid biochanin a: effects and quercetin and EGCG on bioavailability disposition in rats. Mole Pharm 4: 865-72.
25. Moon YJ, Sagawa K, Frederick K, et al. (2006). Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8: 433-42.
26. Mukherjee S, Ray S, Thakur RS. (2009). Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71: 349-58.
27. Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366: 170-84.
28. Silvander M. (2002). Steric stabilization of liposomes - a review. Progr Colloid Polym Sci 120: 35-40.
29. Singh SP, Wahajuddin Ali MM, et al. (2010). High-throughput quantification of isoflavones, biochanin A and genistein, and their conjugates in female rat plasma using LC-ESI-MS/MS: application in pharmacokinetic study. J Sep Sci 33: 3326-34.
30. Yoon KN, Alam N, Lee KR, et al. (2011). Antioxidant and antityroinase activities of various extracts from the fruiting bodies of Lentinus lepideus. Molecules 6: 2334-47.
31. Zur Muhlen A, Schwarz C, Mehnert W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur J Pharm Biopharm 45: 149-55. (Pubitemid 28167741)